|
WO2006084248A2
|
|
Compositions comprising a platinum complex, lipid, and surfactant
|
|
AU2004274430A1
|
|
Vaccine for treatment and prevention of herpes simplex virus infection
|
|
AU2004229458A1
|
|
Improved heat shock protein-based vaccines and immunotherapies
|
|
CN1816348A
|
|
Improved heat shock protein-based vaccines and immunotherapies
|
|
US2005214312A1
|
|
Heat shock protein-based vaccines and immunotherapies
|
|
KR20060026004A
|
|
Use of lectins to promote oligomerization of glycoproteins and antigenic molecules
|
|
US7420037B2
|
|
Heat shock protein-based vaccines and immunotherapies
|
|
AU2003287048A1
|
|
Heat shock protein binding fragments of cd91, and uses thereof
|
|
EP1578773A2
|
|
Methods and products based on oligomerization of stress proteins
|
|
EP1467755A1
|
|
Compositions comprising immunoreactive reagents and saponins, and methods of use thereof
|
|
US2003147920A1
|
|
Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and QS-21
|
|
WO0236733A2
|
|
Cd36 as a heat shock protein receptor and uses thereof
|
|
AU5008801A
|
|
Novel saponin compositions and uses thereof
|
|
AU5131601A
|
|
Isolated and purified nonpeptide antigens from mycobacterium tuberculosis
|
|
CA2397374A1
|
|
Innate immunity-stimulating compositions of cpg and saponin and methods thereof
|
|
EP1250150A2
|
|
Innate immunity-stimulating compositions of cpg and saponin and methods thereof
|
